Inventor · disambiguated record
Gennaro De Libero
Also filed as: DE LIBERO GENNARO
5 granted patents·5 pending applications·3 citations·filing 2004–2023
64Inventor score
Top patents by PatentIndex Score
10 records- 0173US9539222B2Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediated diseasesAGENCY SCIENCE TECH & RES·Filed 2013·Granted Jan 10, 2017·1 cites·15 claims
- 0254US11702459B2MR1 restricted T cell receptors for cancer immunotherapyUNIV BASEL·Filed 2019·Granted Jul 18, 2023·0 cites·16 claims
- 0354US2024002465A1Mr1 restricted t cell receptors for cancer immunotherapyUNIV BASEL·Filed 2023·Application pending·0 cites
- 0453US8268801B2Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosisPUZO GERMAIN·Filed 2008·Granted Sep 18, 2012·2 cites·18 claims
- 0541US8153610B2Sulfoglycolipid antigens, their extraction from Mycobacterium tuberculosis, and their use against tuberculosisPUZO GERMAIN·Filed 2004·Granted Apr 10, 2012·0 cites·20 claims
- 0640US2023099822A1Mr1 ligands and pharmaceutical compositions for immunomodulationUNIV BASEL·Filed 2021·Application pending·0 cites
- 0739US2022339271A1Mr1 restricted t cell receptors for cancer immunotherapyUNIV BASEL·Filed 2019·Application pending·0 cites
- 0838US2018128824A1Novel design of enzyme-linked immunosorbent assay plates and systems and methods of use thereofAGENCY SCIENCE TECH & RES·Filed 2016·Application pending·0 cites
- 0933US2010255015A1Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosisPUZO GERMAIN·Filed 2008·Application pending·0 cites
- 1032US10588962B2Carbohydrate-glycolipid conjugate vaccinesMAX PLANCK GESELLSCHAFT·Filed 2013·Granted Mar 17, 2020·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Gennaro De Libero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →